Map Explore Ask

More ▾

Track recordWhat has been tried, and how it went Read with AIAsk one trial or paper, answered in its own words CompareTwo to ten studies side by side MatchLabs that should be talking DigestWhat is new today FundingWhere the money is, and is not

Search/

Sources: ClinicalTrials.gov · Europe PMC · NIH RePORTER · OpenAlexContracts 0.3.3Research and education only, not treatment advice

what is known about trial:nct:NCT06897644

Question

Understood asRecord NCT06897644View getStudy → table

Gemcitabine Plus Nab-paclitaxel as Switch Maintenance Versus Continuation of Modified FOLFIRINOX as 1st Line Chemotherapy in Patients With Advanced Pancreatic Cancer. NCT06897644 ↗ Outcome: Ongoing

Computed from the knowledge API (getStudy); every record links to its source.

Read it with AI